Tissue Repair Ltd (TRP) - Total Liabilities
Based on the latest financial reports, Tissue Repair Ltd (TRP) has total liabilities worth AU$607.50K AUD (≈ $429.85K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tissue Repair Ltd - Total Liabilities Trend (2020–2025)
This chart illustrates how Tissue Repair Ltd's total liabilities have evolved over time, based on quarterly financial data. See Tissue Repair Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Tissue Repair Ltd Competitors by Total Liabilities
The table below lists competitors of Tissue Repair Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Traka Resources Ltd
AU:TKL
|
Australia | AU$184.14K |
|
Quest PharmaTech Inc
V:QPT
|
Canada | CA$1.25 Million |
|
Cemtrex Inc
NASDAQ:CETX
|
USA | $36.03 Million |
|
Nichols
LSE:NICL
|
UK | GBX42.61 Million |
|
Octopus Renewables Infra Trust
LSE:ORIT
|
UK | GBX1.50 Million |
|
Brüder Mannesmann Aktiengesellschaft
F:BMM
|
Germany | €49.16 Million |
|
Restore plc
LSE:RST
|
UK | GBX394.90 Million |
|
MOJ S.A
WAR:MOJ
|
Poland | zł38.00 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down Tissue Repair Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tissue Repair Ltd (TRP) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 20.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tissue Repair Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tissue Repair Ltd (2020–2025)
The table below shows the annual total liabilities of Tissue Repair Ltd from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$662.53K ≈ $468.79K |
-50.96% |
| 2024-06-30 | AU$1.35 Million ≈ $955.85K |
+171.62% |
| 2023-06-30 | AU$497.35K ≈ $351.90K |
-11.13% |
| 2022-06-30 | AU$559.64K ≈ $395.98K |
+4.41% |
| 2021-06-30 | AU$536.00K ≈ $379.25K |
+62.86% |
| 2020-06-30 | AU$329.11K ≈ $232.87K |
-- |
About Tissue Repair Ltd
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical … Read more